We are delighted to invite you to attend our 10th international Oxford conference on antisense and therapeutic nucleic acids, which will be held as a ‘virtual/in-person’ hybrid event at Oxford (UK) on 20-21 March 2024.
The conference is aimed at bringing together chemists and biologists from academia and industry to discuss the latest advances and breakthroughs in the development of synthetic oligonucleotides as therapeutics, and will feature:
>High-impact talks and discussions
>An international faculty of senior and emerging researchers from academia and industry
Get involved in shaping the conference agenda: We invite oral and poster abstracts on therapeutic applications of nucleic acids, including:
>Antisense & catalytic oligonucloetides, aptamers, siRNAs, miRNAs, antagomirs/blockmirs
>Nucleic acid-based vaccines (viral vectors, mRNA)
>Gene therapy and genome editing
>Chemical modification of nucleic acids
>Nucleic acid delivery strategies
We particularly encourage final year doctoral students and early/mid-career postdoctoral researchers/junior group leaders to submit abstracts, as we believe this event will provide their research an excellent exposure, critical analysis by attending senior researchers and new career opportunities.
Our accompanying aptamers meeting, Aptamers 2024, will be held on 18-19 March 2024.
For further information visit: http://lpmhealthcare.com/oligo-2024-Oxford